Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Chairperson
Joseph Paul Eder
Yale University, New Haven, CT, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
Renier Brentjens
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Discussant
Carl H. June
Abramson Cancer Ctr. of Univ. of Penn., Philadelphia, PA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Clinical safety and activity in a phase I trial of AG-221, a first in class, potent inhibitor of the IDH2-mutant protein, in patients with IDH2 mutant positive advanced hematologic malignancies
Eytan Stein
Memorial Sloan-Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Discussant
John C. Byrd
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome
Adil I. Daud
UCSF School of Medicine, San Francisco, CA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression
Leena Gandhi
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2014 on April 6, 2014 3:15 PM-5:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7